What is it about?
This report showed that cachexia and sarcopenia exist not only at baseline but also at mid- and post-chemotherapeutic period in NSCLC, which always have prognostic value.
Featured Image
Photo by Alexey Ruban on Unsplash
Why is it important?
Although factors predictive of reversibility of cachexia are not known, our data suggests that the management of gastrointestinal toxicities during chemotherapy might be important to reverse cachectic status.
Perspectives
Supportive care for chemotherpeutic toxicities as well as effective pharmacological and/or non-pharmacological interventions for cancer cachexia might reverse cachectic or sarcopenic status and prolong survival in patients with advanced NSCLC.
MD. PhD. Tateaki Naito
Shizuoka Cancer Center
Read the Original
This page is a summary of: Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancer, Supportive Care in Cancer, November 2014, Springer Science + Business Media,
DOI: 10.1007/s00520-014-2534-3.
You can read the full text:
Resources
Contributors
The following have contributed to this page
